| Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics N Berger, A Sachse, J Bender, R Schubert, M Brandl International journal of pharmaceutics 223 (1-2), 55-68, 2001 | 345 | 2001 |
| Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ... European Journal of Pharmaceutical Sciences 137, 104967, 2019 | 290 | 2019 |
| Drug permeability across a phospholipid vesicle based barrier: A novel approach for studying passive diffusion GE Flaten, AB Dhanikula, K Luthman, M Brandl European journal of pharmaceutical sciences 27 (1), 80-90, 2006 | 224 | 2006 |
| Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations” ST Buckley, KJ Frank, G Fricker, M Brandl European journal of pharmaceutical sciences 50 (1), 8-16, 2013 | 211 | 2013 |
| Preparation of liposomes J Lasch, V Weissig, M Brandl Liposomes: a practical approach 2, 24-25, 2003 | 204 | 2003 |
| Liposomes as drug carriers: a technological approach M Brandl Elsevier 7, 59-85, 2001 | 201 | 2001 |
| Drug permeability profiling using cell-free permeation tools: Overview and applications P Berben, A Bauer-Brandl, M Brandl, B Faller, GE Flaten, AC Jacobsen, ... European Journal of Pharmaceutical Sciences 119, 219-233, 2018 | 189 | 2018 |
| Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement KJ Frank, KM Rosenblatt, U Westedt, P Hölig, J Rosenberg, M Mägerlein, ... International journal of pharmaceutics 437 (1-2), 288-293, 2012 | 159 | 2012 |
| In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives ST Buckley, SM Fischer, G Fricker, M Brandl European journal of pharmaceutical sciences 45 (3), 235-250, 2012 | 154 | 2012 |
| Liposome preparation by a new high pressure homogenizer Gaulin Micron Lab 40 M Brandl, D Bachmann, M Drechsler, KH Bauer Drug Development and Industrial Pharmacy 16 (14), 2167-2191, 1990 | 152 | 1990 |
| Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies S Martins, I Tho, I Reimold, G Fricker, E Souto, D Ferreira, M Brandl International journal of pharmaceutics 439 (1-2), 49-62, 2012 | 148 | 2012 |
| 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties N Kaiser, A Kimpfler, U Massing, AM Burger, HH Fiebig, M Brandl, ... International journal of pharmaceutics 256 (1-2), 123-131, 2003 | 140 | 2003 |
| Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media I Tho, B Liepold, J Rosenberg, M Maegerlein, M Brandl, G Fricker European Journal of Pharmaceutical Sciences 40 (1), 25-32, 2010 | 136 | 2010 |
| Liposome size analysis by dynamic/static light scattering upon size exclusion-/field flow-fractionation S Hupfeld, AM Holsæter, M Skar, CB Frantzen, M Brandl Journal of nanoscience and nanotechnology 6 (9-10), 3025-3031, 2006 | 134 | 2006 |
| Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels R Moog, A Burger, M Brandl, J Schüler, R Schubert, C Unger, H Fiebig, ... Cancer chemotherapy and pharmacology 49, 356-366, 2002 | 119 | 2002 |
| What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? KJ Frank, U Westedt, KM Rosenblatt, P Hölig, J Rosenberg, M Mägerlein, ... Journal of pharmaceutical sciences 103 (6), 1779-1786, 2014 | 109 | 2014 |
| In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation J Kanzer, S Hupfeld, T Vasskog, I Tho, P Hölig, M Mägerlein, G Fricker, ... Journal of pharmaceutical and biomedical analysis 53 (3), 359-365, 2010 | 91 | 2010 |
| Oral bioavailability enhancement through supersaturation: an update and meta-analysis SYK Fong, A Bauer-Brandl, M Brandl Expert opinion on drug delivery 14 (3), 403-426, 2017 | 90 | 2017 |
| Distearoylphosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery TJ Evjen, EA Nilssen, S Rögnvaldsson, M Brandl, SL Fossheim European Journal of Pharmaceutics and Biopharmaceutics 75 (3), 327-333, 2010 | 90 | 2010 |
| Drug permeability across a phospholipid vesicle-based barrier: 2. Characterization of barrier structure, storage stability and stability towards pH changes GE Flaten, H Bunjes, K Luthman, M Brandl European journal of pharmaceutical sciences 28 (4), 336-343, 2006 | 87 | 2006 |
Annette Bauer-BrandlUniversity of Southern DenmarkBestätigte E-Mail-Adresse bei sdu.dk
